Pfizer’s stock has been a relative underperformer within the SIA reports, with a well-developed long-term Head and Shoulders pattern that many advisors may witness in real time. The chart reveals a steady decline following a significant surge, with the price now testing critical support near the neckline at $23.91. This pattern, combined with the stock’s consistent underperformance relative to its peers, makes this setup particularly notable for advisors tracking its movements on the SIA platform.